Verona Pharma plc, announces the American Journal of Respiratory and Critical Care Medicine has published results from its Phase 3 ENHANCE trials evaluating ensifentrine in chronic obstructive pulmonary disease.
Verona Pharma plc, announces the American Journal of Respiratory and Critical Care Medicine has published results from its Phase 3 ENHANCE trials evaluating ensifentrine in chronic obstructive pulmonary disease.